Glucokinase maturity-onset diabetes of the young as a mimicker of stress hyperglycemia: a case report

被引:0
作者
Nakasato, Yoshitaka [1 ]
Terashita, Shintaro [2 ,7 ]
Kusabiraki, Shohei [1 ]
Horie, Sadashi [2 ]
Wada, Takuya [3 ]
Nakabayashi, Motokazu [4 ]
Nakamura, Megumi [5 ]
Yorifuji, Tohru [6 ]
机构
[1] Itoigawa Gen Hosp, Dept Pediat, Niigata, Japan
[2] Toyama Univ Hosp, Dept Pediat, Toyama, Japan
[3] Toyama City Hosp, Dept Pediat, Toyama, Japan
[4] Hida Municipal Hosp, Dept Pediat, Gifu, Japan
[5] Nakamura Childrens Clin, Niigata, Japan
[6] Osaka City Gen Hosp, Childrens Med Ctr, Div Pediat Endocrinol & Metab, Osaka, Japan
[7] Univ Toyama, Fac Med, Dept Pediat, 2630 Sugitani, Toyama, Toyama 9300194, Japan
关键词
glucokinase; stress hyperglycemia; maturity-onset diabetes of the young; PREVALENCE; CHILDREN; MODY;
D O I
10.1297/cpe.32.2022-0024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Febrile seizures are frequently accompanied by stress-induced hyperglycemia. Herein, we report the case of a 1.5-yr-old girl with hyperglycemia during febrile seizures who was subsequently diagnosed with glucokinase (GCK) maturity-onset diabetes of the young (MODY), considering its distinction from stress hyperglycemia. Following the development of febrile seizures owing to adenovirus infection, the patient presented a casual blood glucose level was 185 mg/dL. She had a multigenerational family history of diabetes and a hemoglobin A1c (HbA1c) level of 6.4%. Owing to the persistent glucose intolerance until the age of 5 years, genetic testing was performed, which revealed a heterozygous mutation in GCK, and the patient was diagnosed with GCK-MODY. Precise diagnosis of GCK-MODY individuals is important to avoid administering unnecessary antidiabetic medications. Even during hyperglycemia under stress, multigenerational diabetes and mildly elevated HbA1c levels can suggest GCK-MODY.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 15 条
[1]  
Ballerini MG, 2016, ARCH ARGENT PEDIATR, V114, P329, DOI [10.5546/aap.2016.329, 10.5546/aap.2016.eng.329]
[2]   Approach to the Patient with MODY-Monogenic Diabetes [J].
Broome, David T. ;
Pantalone, Kevin M. ;
Kashyap, Sangeeta R. ;
Philipson, Louis H. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01) :237-250
[3]   GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated [J].
Carmody, David ;
Naylor, Rochelle N. ;
Bell, Charles D. ;
Berry, Shivani ;
Montgomery, Jazzmyne T. ;
Tadie, Elizabeth C. ;
Hwang, Jessica L. ;
Greeley, Siri Atma W. ;
Philipson, Louis H. .
ACTA DIABETOLOGICA, 2016, 53 (05) :703-708
[4]   The 0.1% of the Population With Glucokinase Monogenic Diabetes Can Be Recognized by Clinical Characteristics in Pregnancy: The Atlantic Diabetes in Pregnancy Cohort [J].
Chakera, Ali J. ;
Spyer, Gill ;
Vincent, Nicola ;
Ellard, Sian ;
Hattersley, Andrew T. ;
Dunne, Fidelma P. .
DIABETES CARE, 2014, 37 (05) :1230-1236
[5]   Stress Hyperglycemia as Predictive Factor of Recurrence in Children with Febrile Seizures [J].
Costea, Raluca Maria ;
Maniu, Ionela ;
Dobrota, Luminita ;
Neamtu, Bogdan .
BRAIN SCIENCES, 2020, 10 (03)
[6]   Stress hyperglycaemia [J].
Dungan, Kathleen M. ;
Braithwaite, Susan S. ;
Preiser, Jean-Charles .
LANCET, 2009, 373 (9677) :1798-1807
[7]   Non-Diabetic Hyperglycemia in the Pediatric Age: Why, How, and When to Treat? [J].
Fattorusso, Valentina ;
Nugnes, Rosa ;
Casertano, Alberto ;
Valerio, Giuliana ;
Mozzillo, Enza ;
Franzese, Adriana .
CURRENT DIABETES REPORTS, 2018, 18 (12)
[8]   CLOSE LINKAGE OF GLUCOKINASE LOCUS ON CHROMOSOME-7P TO EARLY-ONSET NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
FROGUEL, P ;
VAXILLAIRE, M ;
SUN, F ;
VELHO, G ;
ZOUALI, H ;
BUTEL, MO ;
LESAGE, S ;
VIONNET, N ;
CLEMENT, K ;
FOUGEROUSSE, F ;
TANIZAWA, Y ;
WEISSENBACH, J ;
BECKMANN, JS ;
LATHROP, GM ;
PASSA, P ;
PERMUTT, MA ;
COHEN, D .
NATURE, 1992, 356 (6365) :162-164
[9]   The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing [J].
GoodSmith, Matthew S. ;
Skandari, M. Reza ;
Huang, Elbert S. ;
Naylor, Rochelle N. .
DIABETES CARE, 2019, 42 (12) :2247-2255
[10]   Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications [J].
Naylor, Rochelle N. ;
John, Priya M. ;
Winn, Aaron N. ;
Carmody, David ;
Greeley, Siri Atma W. ;
Philipson, Louis H. ;
Bell, Graeme I. ;
Huang, Elbert S. .
DIABETES CARE, 2014, 37 (01) :202-209